Walvax Biotechnology Co., Ltd. (SHE:300142)

China · Delayed Price · Currency is CNY

15.26

+0.84 (5.83%)

Aug 26, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Autonomous Vaccine	2.15B	2.54B		5.04B	3.43B	-
Technical Service	9.88M	201.21M		16.55M	-	-
Intermediate Products	250.49M	60.26M		27.16M	23.88M	-
Other	5.72M	17.86M		7.65M	10.50M	-
Production Division	-	-		-	-	2.95B
Research and Development (R&D) Division	-	-		-	-	131.45M
Offset of Business Segment	-	-		-	-	-145.47M
Technical Services	-	-		-	45.28K	-
Total	2.42B	2.82B		5.09B	3.46B	2.94B

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Northeast and North China	213.01M	252.42M		567.36M	365.48M	468.11M
Eastern China	679.27M	874.69M		1.71B	1.31B	842.60M
South China Region	400.71M	404.62M		838.37M	518.34M	427.54M
Central China Region	256.31M	332.25M		771.53M	637.01M	713.32M
Southwest Northwest Region	346.88M	387.18M		916.10M	567.95M	530.09M
Overseas Region	522.04M	570.29M		283.41M	65.87M	102.83M
Intersegment Offset	-	-		-	-	-145.47M
Total	2.42B	2.82B		5.09B	3.46B	2.94B